Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Terminix First Shipment

20 Apr 2009 07:00

RNS Number : 7838Q
TyraTech, Inc.
20 April 2009
 



For immediate release

20 April 2009

TYRATECH, INC.

("TyraTech" or "the Company")

FIRST PRODUCT ORDER SHIPPED TO TERMINIX

TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, is pleased to announce that it has shipped the first order of Terminix SafeShield™ to its commercialisation partner, Terminix International ("Terminix"). Terminix, the largest professional pest control company in the world, announced on 20 March 2009 a new program based on Terminix SafeShield, an environmentally responsible pesticide for use against crawling and flying household insects. Terminix SafeShield will be provided to new pest control customers in CaliforniaFloridaGeorgiaOklahoma, and Texas beginning 3 April 2009 and will allow customers to use SafeShield to complement their Terminix pest control services. Terminix SafeShield will also be available for purchase nationally at www.safeshield.com starting 1 May 2009

SafeShield, which is sold packaged in an easy-to-use, 16-ounce non-aerosol spray bottle, was developed by TyraTech using proprietary TyraTech Naturals that are exempt from the EPA regulations for registration of pesticides. TyraTech signed a strategic partnership with Terminix in November 2008 to develop, market and co-brand SafeShield and other TyraTech Naturals products. This collaborative commercialization relationship is intended to combine and leverage Terminix's strong brand and position as a seasoned market leader in pest control with TyraTech's technology and innovation capabilities.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "The shipment of the first order of SafeShieldTM is an exciting revenue generating milestone for the company as we progress further along the development path as a major commercial company. We are proud of the Terminix SafeShield product, as we believe it represents an unparalleled capability for safe and effective insect control for homes and businesses. Our enthusiasm extends to our partner Terminix, the industry leader who has shown a real commitment to move forward with eco-friendly products such as SafeShield."

As one of the world's largest pest control companies, Terminix provides pest control for over 2.8 million homes and businesses against a variety of pests in 45 US states and in 14 countries internationally through its network of 864 service centers worldwide. In its release announcing the new the Terminix SafeShield product, Tom Brackett, Terminix president and chief operating officer, said: "Consumers no longer need to turn to harsh off-the-shelf products to eliminate the occasional indoor pest."

For further information please contact:

TyraTech Inc.

Douglas Armstrong Ph.D., Chief Executive Officer +1 (321) 409 7723

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker/Clare Terlouw +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

MaryߛJane Elliott / Lisa Baderoon +44 (0)20 7466 5000 / Catherine Breen / Stasa Filiplic

www.buchanan.uk.com

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGGMDKNVGLZM
Date   Source Headline
24th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSMigration of shares
6th Aug 20157:00 amRNSMigration of Shares
30th Jul 20154:38 pmRNSResult of AGM
3rd Jul 20155:04 pmRNSMigration of Shares
22nd Jun 20157:00 amRNSFinal Results
10th Jun 20152:22 pmRNSMigration of Shares
26th May 20157:01 amRNSSmartPak launches OutSmart insect repellent
21st May 20155:45 pmRNSMigration of Shares
22nd Apr 20157:00 amRNSDirector's Dealings
20th Apr 20157:00 amRNSEnvance LLC amended: Sharpened strategic focus
9th Apr 20151:14 pmRNSMigration of Shares
8th Apr 20157:00 amRNSListing with Walgreens in the USA
27th Mar 20159:41 amRNSMigration of Shares and Exercise of SARs
25th Mar 20157:00 amRNSVamousse now distributed by CVS in the USA
3rd Mar 20157:00 amRNSVamousse now listed by the top 3 distributors, USA
25th Feb 20157:00 amRNSLloyds and Day Lewis Pharmacy listings
16th Feb 20155:01 pmRNSDirector's Dealings
2nd Feb 20157:00 amRNSVamousse at Walmart and Cardinal Health USA
26th Jan 20157:00 amRNSInnovators and Investors Forum, London
15th Jan 20157:00 amRNSAppointment of Chief Financial Officer & Treasurer
2nd Dec 20147:00 amRNSTrading Update
1st Oct 20147:00 amRNSExercise of Warrants
29th Sep 20147:00 amRNSInterim Results
27th Aug 20147:00 amRNSVamousse products coming to Sainsbury's and Tesco
8th Aug 201410:30 amRNSHolding(s) in Company
5th Aug 201410:29 amRNSHolding(s) in Company
1st Aug 20145:49 pmRNSHolding(s) in Company
1st Aug 20142:40 pmRNSHolding(s) in Company
28th Jul 20145:35 pmRNSResult of Special Meeting & Director Shareholdings
16th Jul 20147:00 amRNSResult of AGM
16th Jul 20147:00 amRNSPlacing to raise £3.5m and launch of UK Vamousse
26th Jun 20147:00 amRNSFinal Results
22nd May 20144:02 pmRNSMigration of Shares
19th May 20146:15 pmRNSMigration of Shares
19th May 20147:00 amRNSVamousse product line available online across USA
30th Apr 20147:00 amRNSNatunex product launched across USA
24th Apr 20147:00 amRNSUSA Pest Control Patents Secured
8th Apr 20146:10 pmRNSDirector's Dealings
7th Apr 20144:41 pmRNSDirector's Dealings
1st Apr 20147:00 amRNSVamousse at over 4,000 Walmart Stores in USA
7th Mar 20147:00 amRNSMigration of Shares
6th Mar 201411:48 amRNSHolding(s) in Company
6th Mar 20147:00 amRNSAward of Share Options
24th Feb 20147:00 amRNSProposed Migration of Shares
18th Feb 20143:38 pmRNSResult of Special Meeting
13th Feb 20149:47 amRNSHolding(s) in Company
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.